Literature DB >> 31157019

Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.

Gabriel Estan-Cerezo1, Carmen Matoses-Chirivella1, Leticia Soriano-Irigaray1, Ana Cristina Murcia-López1, Francisco José Rodríguez-Lucena1, Andrés Navarro-Ruiz1.   

Abstract

BACKGROUND: The chemical stability of coadministered ondansetron (OND) and haloperidol (HAL) in parenteral admixtures has not been described yet.
OBJECTIVE: The aim of the present work is to study the chemical stability and the compatibility of OND and HAL admixtures.
METHODS: Normal saline solution and dextrose were used to prepare the admixture solutions of the drugs; the materials of the containers were the original plastic bags of the diluents and the stability was studied at 20°C. Compatibility was studied by visual inspection of no colour change and turbidity or precipitation appearance. The concentration of the drugs was studied by ultraviolet detection high-performance liquid chromatography. The method was validated following the Food and Drug Administration and European Medicines Agency guidelines, and the assay enables the measurement of both drugs with a linear calibration curve (r=0.999) over the concentration range 10-100 µg/mL, with acceptable values of linearity, precision and accuracy. Darunavir was used as internal standard.
RESULTS: Most of the admixtures have an adequate concentration until 24 hours(less than 10% of loss). 25% of the samples show a higher loss at 24 hours, and the chemical stability of these samples is 12 hours.
CONCLUSIONS: The stability and compatibility of OND and HAL in the coadministered admixtures in Viaflo plastic bags with normal saline or dextrose are suggested at 12 hours.

Entities:  

Keywords:  HPLC; chemical stability; haloperidol; ondansetron; validated studies

Year:  2017        PMID: 31157019      PMCID: PMC6452387          DOI: 10.1136/ejhpharm-2016-001200

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  14 in total

1.  Stability of ondansetron and dexamethasone infusion upon refrigeration.

Authors:  Catherine Rolin; Jean-Daniel Hecq; Danielle F Vanbeckbergen; Jacques Jamart; Laurence M Galanti
Journal:  Ann Pharmacother       Date:  2010-12-14       Impact factor: 3.154

2.  Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.

Authors:  L A Trissel; S M Tramonte; B J Grilley
Journal:  Am J Hosp Pharm       Date:  1991-05

3.  Avoiding common flaws in stability and compatibility studies of injectable drugs.

Authors:  L A Trissel
Journal:  Am J Hosp Pharm       Date:  1983-07

4.  Stability of haloperidol in 5% dextrose injection.

Authors:  V Das Gupta; K R Stewart
Journal:  Am J Hosp Pharm       Date:  1982-02

5.  Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.

Authors:  Sofía Negro; Alicia Martín; María Luz Azuara; Yolanda Sánchez; Emilia Barcia
Journal:  J Pain Symptom Manage       Date:  2005-08       Impact factor: 3.612

6.  Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: retrospective clinical evaluation.

Authors:  Sofia Negro; Alicia Martín; Luz Azuara; Yolanda Sánchez; Emilia Barcia
Journal:  J Palliat Med       Date:  2010-03       Impact factor: 2.947

7.  Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.

Authors:  A Vermeire; J P Remon
Journal:  Int J Pharm       Date:  1999-01-15       Impact factor: 5.875

8.  Stability of ondansetron in large-volume parenteral solutions.

Authors:  C L Graham; G E Dukes; C F Kao; J M Bertch; L J Hak
Journal:  Ann Pharmacother       Date:  1992-06       Impact factor: 3.154

9.  Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.

Authors:  Emilia Barcia; Rodrigo Reyes; María Luz Azuara; Yolanda Sánchez; Sofía Negro
Journal:  Support Care Cancer       Date:  2003-01-10       Impact factor: 3.603

Review 10.  Treating nausea and vomiting in palliative care: a review.

Authors:  Paul Glare; Jeanna Miller; Tanya Nikolova; Roma Tickoo
Journal:  Clin Interv Aging       Date:  2011-09-12       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.